nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—kidney cancer	0.264	1	CbGaD
Sitagliptin—ABCB1—Temsirolimus—kidney cancer	0.0521	0.103	CbGbCtD
Sitagliptin—CYP3A4—Everolimus—kidney cancer	0.0462	0.0909	CbGbCtD
Sitagliptin—CYP2C8—Pazopanib—kidney cancer	0.0404	0.0796	CbGbCtD
Sitagliptin—CYP3A4—Temsirolimus—kidney cancer	0.0312	0.0614	CbGbCtD
Sitagliptin—CYP2C8—Erlotinib—kidney cancer	0.0288	0.0568	CbGbCtD
Sitagliptin—ABCB1—Pazopanib—kidney cancer	0.0274	0.0539	CbGbCtD
Sitagliptin—CYP2C8—Paclitaxel—kidney cancer	0.0264	0.052	CbGbCtD
Sitagliptin—ABCB1—Dactinomycin—kidney cancer	0.025	0.0493	CbGbCtD
Sitagliptin—CYP2C8—Sorafenib—kidney cancer	0.0235	0.0462	CbGbCtD
Sitagliptin—ABCB1—Gemcitabine—kidney cancer	0.0198	0.0389	CbGbCtD
Sitagliptin—ABCB1—Erlotinib—kidney cancer	0.0195	0.0384	CbGbCtD
Sitagliptin—ABCB1—Paclitaxel—kidney cancer	0.0179	0.0352	CbGbCtD
Sitagliptin—CYP3A4—Pazopanib—kidney cancer	0.0164	0.0323	CbGbCtD
Sitagliptin—ABCB1—Sorafenib—kidney cancer	0.0159	0.0312	CbGbCtD
Sitagliptin—ABCB1—Vinblastine—kidney cancer	0.0157	0.0309	CbGbCtD
Sitagliptin—ABCB1—Vincristine—kidney cancer	0.0154	0.0303	CbGbCtD
Sitagliptin—ABCB1—Sunitinib—kidney cancer	0.0129	0.0253	CbGbCtD
Sitagliptin—CYP3A4—Erlotinib—kidney cancer	0.0117	0.023	CbGbCtD
Sitagliptin—CYP3A4—Paclitaxel—kidney cancer	0.0107	0.0211	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—kidney cancer	0.00963	0.019	CbGbCtD
Sitagliptin—CYP3A4—Sorafenib—kidney cancer	0.00951	0.0187	CbGbCtD
Sitagliptin—CYP3A4—Vinblastine—kidney cancer	0.00939	0.0185	CbGbCtD
Sitagliptin—CYP3A4—Vincristine—kidney cancer	0.00923	0.0182	CbGbCtD
Sitagliptin—CYP3A4—Sunitinib—kidney cancer	0.00771	0.0152	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—kidney cancer	0.00577	0.0114	CbGbCtD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—PAX6—kidney cancer	0.00167	0.0747	CbGpPWpGaD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—PAX6—kidney cancer	0.00148	0.0664	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—MME—kidney cancer	0.00069	0.0309	CbGpPWpGaD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—kidney cancer	0.000563	0.0252	CbGpPWpGaD
Sitagliptin—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.000559	0.025	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—ACHE—kidney cancer	0.000529	0.0237	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—kidney cancer	0.000516	0.0231	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—PAX6—kidney cancer	0.000503	0.0225	CbGpPWpGaD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—kidney cancer	0.000501	0.0224	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—CTSD—kidney cancer	0.000501	0.0224	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—BCHE—kidney cancer	0.000461	0.0206	CbGpPWpGaD
Sitagliptin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—kidney cancer	0.000404	0.0181	CbGpPWpGaD
Sitagliptin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—kidney cancer	0.000368	0.0165	CbGpPWpGaD
Sitagliptin—CYP3A4—urine—kidney cancer	0.000353	0.165	CbGeAlD
Sitagliptin—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000351	0.0157	CbGpPWpGaD
Sitagliptin—DPP4—nephron tubule—kidney cancer	0.000292	0.136	CbGeAlD
Sitagliptin—ABCB1—Allograft Rejection—HARS—kidney cancer	0.00029	0.013	CbGpPWpGaD
Sitagliptin—DPP4—renal system—kidney cancer	0.000265	0.124	CbGeAlD
Sitagliptin—DPP4—Metabolism of proteins—EIF5B—kidney cancer	0.000264	0.0118	CbGpPWpGaD
Sitagliptin—DPP4—kidney—kidney cancer	0.000256	0.12	CbGeAlD
Sitagliptin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000255	0.0114	CbGpPWpGaD
Sitagliptin—DPP4—cortex of kidney—kidney cancer	0.00025	0.117	CbGeAlD
Sitagliptin—DPP4—Peptide hormone metabolism—POMC—kidney cancer	0.000238	0.0107	CbGpPWpGaD
Sitagliptin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000236	0.0106	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CUL7—kidney cancer	0.000235	0.0105	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—HSPA9—kidney cancer	0.000224	0.01	CbGpPWpGaD
Sitagliptin—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.0002	0.00896	CbGpPWpGaD
Sitagliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000197	0.00884	CbGpPWpGaD
Sitagliptin—CYP2C8—Xenobiotics—CYP1A1—kidney cancer	0.000194	0.0087	CbGpPWpGaD
Sitagliptin—CYP2C8—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000187	0.00836	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000184	0.00825	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—MUC4—kidney cancer	0.000183	0.00818	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—ACY1—kidney cancer	0.000179	0.008	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—PGK1—kidney cancer	0.000176	0.00788	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—ST3GAL2—kidney cancer	0.000174	0.00778	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—CTNNB1—kidney cancer	0.00017	0.00761	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—EEF2—kidney cancer	0.00017	0.00761	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—LRRK2—kidney cancer	0.000167	0.00746	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	0.000164	0.00732	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000151	0.00676	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—CA9—kidney cancer	0.00015	0.0067	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000145	0.00648	CbGpPWpGaD
Sitagliptin—Skin disorder—Gemcitabine—kidney cancer	0.000143	0.000702	CcSEcCtD
Sitagliptin—Vision blurred—Paclitaxel—kidney cancer	0.000142	0.000699	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000142	0.000697	CcSEcCtD
Sitagliptin—Hypoaesthesia—Capecitabine—kidney cancer	0.000141	0.000696	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000141	0.000694	CcSEcCtD
Sitagliptin—Pharyngitis—Capecitabine—kidney cancer	0.000141	0.000694	CcSEcCtD
Sitagliptin—Urinary tract disorder—Capecitabine—kidney cancer	0.00014	0.00069	CcSEcCtD
Sitagliptin—Hypersensitivity—Sorafenib—kidney cancer	0.00014	0.00069	CcSEcCtD
Sitagliptin—Insomnia—Vincristine—kidney cancer	0.00014	0.000689	CcSEcCtD
Sitagliptin—Oedema peripheral—Capecitabine—kidney cancer	0.00014	0.000689	CcSEcCtD
Sitagliptin—Vomiting—Vinblastine—kidney cancer	0.00014	0.000688	CcSEcCtD
Sitagliptin—Dizziness—Erlotinib—kidney cancer	0.00014	0.000688	CcSEcCtD
Sitagliptin—Ill-defined disorder—Paclitaxel—kidney cancer	0.00014	0.000688	CcSEcCtD
Sitagliptin—Connective tissue disorder—Capecitabine—kidney cancer	0.00014	0.000687	CcSEcCtD
Sitagliptin—Vomiting—Everolimus—kidney cancer	0.000139	0.000686	CcSEcCtD
Sitagliptin—Urethral disorder—Capecitabine—kidney cancer	0.000139	0.000685	CcSEcCtD
Sitagliptin—Renal impairment—Doxorubicin—kidney cancer	0.000139	0.000684	CcSEcCtD
Sitagliptin—Rash—Everolimus—kidney cancer	0.000138	0.00068	CcSEcCtD
Sitagliptin—Dermatitis—Everolimus—kidney cancer	0.000138	0.000679	CcSEcCtD
Sitagliptin—Headache—Vinblastine—kidney cancer	0.000138	0.000678	CcSEcCtD
Sitagliptin—Angioedema—Paclitaxel—kidney cancer	0.000138	0.000678	CcSEcCtD
Sitagliptin—Headache—Everolimus—kidney cancer	0.000137	0.000676	CcSEcCtD
Sitagliptin—Abdominal pain—Dactinomycin—kidney cancer	0.000137	0.000674	CcSEcCtD
Sitagliptin—Asthenia—Sorafenib—kidney cancer	0.000137	0.000672	CcSEcCtD
Sitagliptin—Malaise—Paclitaxel—kidney cancer	0.000136	0.000669	CcSEcCtD
Sitagliptin—Hypoglycaemia—Doxorubicin—kidney cancer	0.000136	0.000667	CcSEcCtD
Sitagliptin—Vertigo—Paclitaxel—kidney cancer	0.000135	0.000666	CcSEcCtD
Sitagliptin—Hypersensitivity—Sunitinib—kidney cancer	0.000135	0.000664	CcSEcCtD
Sitagliptin—Decreased appetite—Vincristine—kidney cancer	0.000135	0.000662	CcSEcCtD
Sitagliptin—Vomiting—Erlotinib—kidney cancer	0.000135	0.000662	CcSEcCtD
Sitagliptin—Erythema multiforme—Capecitabine—kidney cancer	0.000134	0.000661	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000134	0.000659	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000134	0.000658	CcSEcCtD
Sitagliptin—Fatigue—Vincristine—kidney cancer	0.000134	0.000657	CcSEcCtD
Sitagliptin—Rash—Erlotinib—kidney cancer	0.000133	0.000656	CcSEcCtD
Sitagliptin—Dermatitis—Erlotinib—kidney cancer	0.000133	0.000655	CcSEcCtD
Sitagliptin—Insomnia—Gemcitabine—kidney cancer	0.000133	0.000654	CcSEcCtD
Sitagliptin—Eye disorder—Capecitabine—kidney cancer	0.000133	0.000653	CcSEcCtD
Sitagliptin—Headache—Erlotinib—kidney cancer	0.000133	0.000652	CcSEcCtD
Sitagliptin—Constipation—Vincristine—kidney cancer	0.000133	0.000652	CcSEcCtD
Sitagliptin—Pain—Vincristine—kidney cancer	0.000133	0.000652	CcSEcCtD
Sitagliptin—Osteoarthritis—Doxorubicin—kidney cancer	0.000132	0.000651	CcSEcCtD
Sitagliptin—Pain in extremity—Doxorubicin—kidney cancer	0.000132	0.000651	CcSEcCtD
Sitagliptin—Cardiac disorder—Capecitabine—kidney cancer	0.000132	0.000649	CcSEcCtD
Sitagliptin—Cough—Paclitaxel—kidney cancer	0.000132	0.000647	CcSEcCtD
Sitagliptin—Asthenia—Sunitinib—kidney cancer	0.000131	0.000646	CcSEcCtD
Sitagliptin—Nausea—Vinblastine—kidney cancer	0.000131	0.000643	CcSEcCtD
Sitagliptin—Somnolence—Gemcitabine—kidney cancer	0.000131	0.000643	CcSEcCtD
Sitagliptin—Migraine—Doxorubicin—kidney cancer	0.00013	0.000641	CcSEcCtD
Sitagliptin—Nausea—Everolimus—kidney cancer	0.00013	0.000641	CcSEcCtD
Sitagliptin—Diarrhoea—Sorafenib—kidney cancer	0.00013	0.000641	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—MME—kidney cancer	0.00013	0.00583	CbGpPWpGaD
Sitagliptin—Hypertension—Paclitaxel—kidney cancer	0.00013	0.00064	CcSEcCtD
Sitagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000129	0.00578	CbGpPWpGaD
Sitagliptin—Angiopathy—Capecitabine—kidney cancer	0.000129	0.000634	CcSEcCtD
Sitagliptin—Immune system disorder—Capecitabine—kidney cancer	0.000128	0.000631	CcSEcCtD
Sitagliptin—Myalgia—Paclitaxel—kidney cancer	0.000128	0.000631	CcSEcCtD
Sitagliptin—Arthralgia—Paclitaxel—kidney cancer	0.000128	0.000631	CcSEcCtD
Sitagliptin—Mediastinal disorder—Capecitabine—kidney cancer	0.000128	0.00063	CcSEcCtD
Sitagliptin—Anxiety—Paclitaxel—kidney cancer	0.000128	0.000629	CcSEcCtD
Sitagliptin—Face oedema—Doxorubicin—kidney cancer	0.000128	0.000629	CcSEcCtD
Sitagliptin—Decreased appetite—Gemcitabine—kidney cancer	0.000128	0.000628	CcSEcCtD
Sitagliptin—Hypersensitivity—Dactinomycin—kidney cancer	0.000128	0.000628	CcSEcCtD
Sitagliptin—CYP2C8—renal system—kidney cancer	0.000128	0.0597	CbGeAlD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000128	0.000627	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000127	0.000624	CcSEcCtD
Sitagliptin—Discomfort—Paclitaxel—kidney cancer	0.000127	0.000624	CcSEcCtD
Sitagliptin—Fatigue—Gemcitabine—kidney cancer	0.000127	0.000623	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Vincristine—kidney cancer	0.000127	0.000623	CcSEcCtD
Sitagliptin—Dizziness—Sorafenib—kidney cancer	0.000126	0.000619	CcSEcCtD
Sitagliptin—Constipation—Gemcitabine—kidney cancer	0.000126	0.000618	CcSEcCtD
Sitagliptin—Pain—Gemcitabine—kidney cancer	0.000126	0.000618	CcSEcCtD
Sitagliptin—Nausea—Erlotinib—kidney cancer	0.000126	0.000618	CcSEcCtD
Sitagliptin—Dry mouth—Paclitaxel—kidney cancer	0.000126	0.000617	CcSEcCtD
Sitagliptin—Diarrhoea—Sunitinib—kidney cancer	0.000125	0.000616	CcSEcCtD
Sitagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000125	0.00558	CbGpPWpGaD
Sitagliptin—Mental disorder—Capecitabine—kidney cancer	0.000125	0.000612	CcSEcCtD
Sitagliptin—Asthenia—Dactinomycin—kidney cancer	0.000124	0.000612	CcSEcCtD
Sitagliptin—Blood creatinine increased—Doxorubicin—kidney cancer	0.000124	0.00061	CcSEcCtD
Sitagliptin—Malnutrition—Capecitabine—kidney cancer	0.000124	0.000608	CcSEcCtD
Sitagliptin—CYP2C8—kidney—kidney cancer	0.000123	0.0577	CbGeAlD
Sitagliptin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000123	0.000605	CcSEcCtD
Sitagliptin—Abdominal pain—Vincristine—kidney cancer	0.000122	0.000602	CcSEcCtD
Sitagliptin—Infection—Paclitaxel—kidney cancer	0.000122	0.000601	CcSEcCtD
Sitagliptin—Flatulence—Capecitabine—kidney cancer	0.000122	0.0006	CcSEcCtD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	0.000122	0.00545	CbGpPWpGaD
Sitagliptin—Dizziness—Sunitinib—kidney cancer	0.000121	0.000596	CcSEcCtD
Sitagliptin—Feeling abnormal—Gemcitabine—kidney cancer	0.000121	0.000596	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—HSPD1—kidney cancer	0.000121	0.00542	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—RPL14—kidney cancer	0.000121	0.00542	CbGpPWpGaD
Sitagliptin—Vomiting—Sorafenib—kidney cancer	0.000121	0.000595	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000121	0.000595	CcSEcCtD
Sitagliptin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000121	0.000595	CcSEcCtD
Sitagliptin—Nervous system disorder—Paclitaxel—kidney cancer	0.000121	0.000593	CcSEcCtD
Sitagliptin—Rash—Sorafenib—kidney cancer	0.00012	0.00059	CcSEcCtD
Sitagliptin—Dermatitis—Sorafenib—kidney cancer	0.00012	0.00059	CcSEcCtD
Sitagliptin—Back pain—Capecitabine—kidney cancer	0.00012	0.000589	CcSEcCtD
Sitagliptin—Breast disorder—Doxorubicin—kidney cancer	0.00012	0.000589	CcSEcCtD
Sitagliptin—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.00012	0.00536	CbGpPWpGaD
Sitagliptin—Skin disorder—Paclitaxel—kidney cancer	0.00012	0.000588	CcSEcCtD
Sitagliptin—Headache—Sorafenib—kidney cancer	0.000119	0.000586	CcSEcCtD
Sitagliptin—Muscle spasms—Capecitabine—kidney cancer	0.000119	0.000585	CcSEcCtD
Sitagliptin—Diarrhoea—Dactinomycin—kidney cancer	0.000119	0.000583	CcSEcCtD
Sitagliptin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000118	0.000582	CcSEcCtD
Sitagliptin—Vision blurred—Capecitabine—kidney cancer	0.000117	0.000573	CcSEcCtD
Sitagliptin—Vomiting—Sunitinib—kidney cancer	0.000116	0.000573	CcSEcCtD
Sitagliptin—Rash—Sunitinib—kidney cancer	0.000116	0.000568	CcSEcCtD
Sitagliptin—Dermatitis—Sunitinib—kidney cancer	0.000115	0.000567	CcSEcCtD
Sitagliptin—Ill-defined disorder—Capecitabine—kidney cancer	0.000115	0.000565	CcSEcCtD
Sitagliptin—Headache—Sunitinib—kidney cancer	0.000115	0.000564	CcSEcCtD
Sitagliptin—Influenza—Doxorubicin—kidney cancer	0.000114	0.000563	CcSEcCtD
Sitagliptin—Hypersensitivity—Vincristine—kidney cancer	0.000114	0.000561	CcSEcCtD
Sitagliptin—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000113	0.00508	CbGpPWpGaD
Sitagliptin—Nausea—Sorafenib—kidney cancer	0.000113	0.000556	CcSEcCtD
Sitagliptin—Pancreatitis—Doxorubicin—kidney cancer	0.000112	0.000552	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000112	0.000551	CcSEcCtD
Sitagliptin—Malaise—Capecitabine—kidney cancer	0.000112	0.000549	CcSEcCtD
Sitagliptin—Insomnia—Paclitaxel—kidney cancer	0.000111	0.000547	CcSEcCtD
Sitagliptin—Vertigo—Capecitabine—kidney cancer	0.000111	0.000547	CcSEcCtD
Sitagliptin—Asthenia—Vincristine—kidney cancer	0.000111	0.000547	CcSEcCtD
Sitagliptin—Vomiting—Dactinomycin—kidney cancer	0.00011	0.000542	CcSEcCtD
Sitagliptin—Bronchitis—Doxorubicin—kidney cancer	0.00011	0.000541	CcSEcCtD
Sitagliptin—Somnolence—Paclitaxel—kidney cancer	0.000109	0.000538	CcSEcCtD
Sitagliptin—Rash—Dactinomycin—kidney cancer	0.000109	0.000538	CcSEcCtD
Sitagliptin—Nausea—Sunitinib—kidney cancer	0.000109	0.000535	CcSEcCtD
Sitagliptin—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000109	0.00486	CbGpPWpGaD
Sitagliptin—Dyspepsia—Paclitaxel—kidney cancer	0.000108	0.000533	CcSEcCtD
Sitagliptin—Cough—Capecitabine—kidney cancer	0.000108	0.000531	CcSEcCtD
Sitagliptin—Decreased appetite—Paclitaxel—kidney cancer	0.000107	0.000526	CcSEcCtD
Sitagliptin—Hypertension—Capecitabine—kidney cancer	0.000107	0.000525	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000106	0.000523	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000106	0.000522	CcSEcCtD
Sitagliptin—Fatigue—Paclitaxel—kidney cancer	0.000106	0.000522	CcSEcCtD
Sitagliptin—Diarrhoea—Vincristine—kidney cancer	0.000106	0.000521	CcSEcCtD
Sitagliptin—Asthenia—Gemcitabine—kidney cancer	0.000105	0.000519	CcSEcCtD
Sitagliptin—Arthralgia—Capecitabine—kidney cancer	0.000105	0.000518	CcSEcCtD
Sitagliptin—Myalgia—Capecitabine—kidney cancer	0.000105	0.000518	CcSEcCtD
Sitagliptin—Constipation—Paclitaxel—kidney cancer	0.000105	0.000517	CcSEcCtD
Sitagliptin—Pain—Paclitaxel—kidney cancer	0.000105	0.000517	CcSEcCtD
Sitagliptin—Anxiety—Capecitabine—kidney cancer	0.000105	0.000516	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000105	0.000514	CcSEcCtD
Sitagliptin—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000104	0.00467	CbGpPWpGaD
Sitagliptin—Weight increased—Doxorubicin—kidney cancer	0.000104	0.000512	CcSEcCtD
Sitagliptin—Discomfort—Capecitabine—kidney cancer	0.000104	0.000512	CcSEcCtD
Sitagliptin—Hyperglycaemia—Doxorubicin—kidney cancer	0.000103	0.000508	CcSEcCtD
Sitagliptin—Dry mouth—Capecitabine—kidney cancer	0.000103	0.000507	CcSEcCtD
Sitagliptin—Nausea—Dactinomycin—kidney cancer	0.000103	0.000507	CcSEcCtD
Sitagliptin—Pneumonia—Doxorubicin—kidney cancer	0.000103	0.000505	CcSEcCtD
Sitagliptin—Dizziness—Vincristine—kidney cancer	0.000102	0.000504	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—kidney cancer	0.000102	0.000502	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—kidney cancer	0.000102	0.000502	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000101	0.00454	CbGpPWpGaD
Sitagliptin—Feeling abnormal—Paclitaxel—kidney cancer	0.000101	0.000499	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000101	0.000498	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000101	0.000495	CcSEcCtD
Sitagliptin—Diarrhoea—Gemcitabine—kidney cancer	0.000101	0.000495	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—kidney cancer	0.0001	0.000493	CcSEcCtD
Sitagliptin—Infection—Capecitabine—kidney cancer	0.0001	0.000493	CcSEcCtD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.0001	0.00449	CbGpPWpGaD
Sitagliptin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.0001	0.000492	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—ACHE—kidney cancer	9.99e-05	0.00447	CbGpPWpGaD
Sitagliptin—Urinary tract infection—Doxorubicin—kidney cancer	9.92e-05	0.000488	CcSEcCtD
Sitagliptin—Nervous system disorder—Capecitabine—kidney cancer	9.91e-05	0.000487	CcSEcCtD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	9.89e-05	0.00443	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—EIF4EBP1—kidney cancer	9.87e-05	0.00442	CbGpPWpGaD
Sitagliptin—Vomiting—Vincristine—kidney cancer	9.85e-05	0.000484	CcSEcCtD
Sitagliptin—Skin disorder—Capecitabine—kidney cancer	9.81e-05	0.000482	CcSEcCtD
Sitagliptin—CYP2C8—Biological oxidations—ALDH1A1—kidney cancer	9.79e-05	0.00438	CbGpPWpGaD
Sitagliptin—Urticaria—Paclitaxel—kidney cancer	9.78e-05	0.000481	CcSEcCtD
Sitagliptin—Rash—Vincristine—kidney cancer	9.77e-05	0.00048	CcSEcCtD
Sitagliptin—Dermatitis—Vincristine—kidney cancer	9.76e-05	0.00048	CcSEcCtD
Sitagliptin—Abdominal pain—Paclitaxel—kidney cancer	9.73e-05	0.000478	CcSEcCtD
Sitagliptin—Headache—Vincristine—kidney cancer	9.71e-05	0.000477	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—kidney cancer	9.65e-05	0.000475	CcSEcCtD
Sitagliptin—CYP3A4—Biological oxidations—ACY1—kidney cancer	9.59e-05	0.00429	CbGpPWpGaD
Sitagliptin—Sinusitis—Doxorubicin—kidney cancer	9.58e-05	0.000471	CcSEcCtD
Sitagliptin—ABCB1—Allograft Rejection—IL13—kidney cancer	9.51e-05	0.00426	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—PAX6—kidney cancer	9.5e-05	0.00425	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CTSD—kidney cancer	9.45e-05	0.00423	CbGpPWpGaD
Sitagliptin—Vomiting—Gemcitabine—kidney cancer	9.35e-05	0.00046	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—CYP1A1—kidney cancer	9.33e-05	0.00418	CbGpPWpGaD
Sitagliptin—Rash—Gemcitabine—kidney cancer	9.27e-05	0.000456	CcSEcCtD
Sitagliptin—Dermatitis—Gemcitabine—kidney cancer	9.26e-05	0.000455	CcSEcCtD
Sitagliptin—Headache—Gemcitabine—kidney cancer	9.21e-05	0.000453	CcSEcCtD
Sitagliptin—Nausea—Vincristine—kidney cancer	9.2e-05	0.000453	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.2e-05	0.000452	CcSEcCtD
Sitagliptin—Insomnia—Capecitabine—kidney cancer	9.14e-05	0.000449	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—kidney cancer	9.12e-05	0.000448	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—kidney cancer	9.1e-05	0.000447	CcSEcCtD
Sitagliptin—Hypersensitivity—Paclitaxel—kidney cancer	9.07e-05	0.000446	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—kidney cancer	9.05e-05	0.000445	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—kidney cancer	9.03e-05	0.000444	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—kidney cancer	9.01e-05	0.000443	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—kidney cancer	8.98e-05	0.000442	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	8.96e-05	0.00401	CbGpPWpGaD
Sitagliptin—Dyspepsia—Capecitabine—kidney cancer	8.89e-05	0.000437	CcSEcCtD
Sitagliptin—Asthenia—Paclitaxel—kidney cancer	8.83e-05	0.000434	CcSEcCtD
Sitagliptin—Decreased appetite—Capecitabine—kidney cancer	8.78e-05	0.000432	CcSEcCtD
Sitagliptin—Nausea—Gemcitabine—kidney cancer	8.73e-05	0.000429	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Capecitabine—kidney cancer	8.72e-05	0.000429	CcSEcCtD
Sitagliptin—Fatigue—Capecitabine—kidney cancer	8.71e-05	0.000428	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—BCHE—kidney cancer	8.7e-05	0.00389	CbGpPWpGaD
Sitagliptin—Erythema multiforme—Doxorubicin—kidney cancer	8.66e-05	0.000426	CcSEcCtD
Sitagliptin—CYP3A4—renal system—kidney cancer	8.65e-05	0.0404	CbGeAlD
Sitagliptin—Constipation—Capecitabine—kidney cancer	8.64e-05	0.000425	CcSEcCtD
Sitagliptin—Pain—Capecitabine—kidney cancer	8.64e-05	0.000425	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—kidney cancer	8.56e-05	0.000421	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—kidney cancer	8.5e-05	0.000418	CcSEcCtD
Sitagliptin—Diarrhoea—Paclitaxel—kidney cancer	8.42e-05	0.000414	CcSEcCtD
Sitagliptin—CYP3A4—kidney—kidney cancer	8.36e-05	0.0391	CbGeAlD
Sitagliptin—Feeling abnormal—Capecitabine—kidney cancer	8.32e-05	0.000409	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—kidney cancer	8.31e-05	0.000409	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—kidney cancer	8.28e-05	0.000407	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Capecitabine—kidney cancer	8.26e-05	0.000406	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—kidney cancer	8.26e-05	0.000406	CcSEcCtD
Sitagliptin—Dizziness—Paclitaxel—kidney cancer	8.14e-05	0.0004	CcSEcCtD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	8.07e-05	0.00361	CbGpPWpGaD
Sitagliptin—Mental disorder—Doxorubicin—kidney cancer	8.03e-05	0.000395	CcSEcCtD
Sitagliptin—Urticaria—Capecitabine—kidney cancer	8.02e-05	0.000395	CcSEcCtD
Sitagliptin—Abdominal pain—Capecitabine—kidney cancer	7.98e-05	0.000393	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—kidney cancer	7.98e-05	0.000392	CcSEcCtD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.96e-05	0.00356	CbGpPWpGaD
Sitagliptin—Flatulence—Doxorubicin—kidney cancer	7.86e-05	0.000387	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—kidney cancer	7.83e-05	0.000385	CcSEcCtD
Sitagliptin—Vomiting—Paclitaxel—kidney cancer	7.83e-05	0.000385	CcSEcCtD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	7.78e-05	0.00348	CbGpPWpGaD
Sitagliptin—Rash—Paclitaxel—kidney cancer	7.76e-05	0.000382	CcSEcCtD
Sitagliptin—Dermatitis—Paclitaxel—kidney cancer	7.75e-05	0.000381	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—kidney cancer	7.75e-05	0.000381	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—kidney cancer	7.72e-05	0.000379	CcSEcCtD
Sitagliptin—Headache—Paclitaxel—kidney cancer	7.71e-05	0.000379	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—kidney cancer	7.67e-05	0.000377	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—kidney cancer	7.52e-05	0.00037	CcSEcCtD
Sitagliptin—Hypersensitivity—Capecitabine—kidney cancer	7.44e-05	0.000366	CcSEcCtD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	7.41e-05	0.00332	CbGpPWpGaD
Sitagliptin—Ill-defined disorder—Doxorubicin—kidney cancer	7.4e-05	0.000364	CcSEcCtD
Sitagliptin—Nausea—Paclitaxel—kidney cancer	7.31e-05	0.000359	CcSEcCtD
Sitagliptin—Asthenia—Capecitabine—kidney cancer	7.25e-05	0.000356	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—kidney cancer	7.19e-05	0.000354	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—kidney cancer	7.17e-05	0.000352	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—kidney cancer	6.96e-05	0.000342	CcSEcCtD
Sitagliptin—Diarrhoea—Capecitabine—kidney cancer	6.91e-05	0.00034	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—kidney cancer	6.89e-05	0.000339	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—kidney cancer	6.79e-05	0.000334	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—kidney cancer	6.79e-05	0.000334	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—kidney cancer	6.77e-05	0.000333	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.74e-05	0.000332	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—IGF2—kidney cancer	6.74e-05	0.00302	CbGpPWpGaD
Sitagliptin—ABCB1—nephron tubule—kidney cancer	6.73e-05	0.0315	CbGeAlD
Sitagliptin—Discomfort—Doxorubicin—kidney cancer	6.71e-05	0.00033	CcSEcCtD
Sitagliptin—Dizziness—Capecitabine—kidney cancer	6.68e-05	0.000328	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—kidney cancer	6.64e-05	0.000327	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.54e-05	0.00293	CbGpPWpGaD
Sitagliptin—Anaphylactic shock—Doxorubicin—kidney cancer	6.51e-05	0.00032	CcSEcCtD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	6.47e-05	0.0029	CbGpPWpGaD
Sitagliptin—Infection—Doxorubicin—kidney cancer	6.47e-05	0.000318	CcSEcCtD
Sitagliptin—Vomiting—Capecitabine—kidney cancer	6.42e-05	0.000316	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—kidney cancer	6.38e-05	0.000314	CcSEcCtD
Sitagliptin—Rash—Capecitabine—kidney cancer	6.37e-05	0.000313	CcSEcCtD
Sitagliptin—Dermatitis—Capecitabine—kidney cancer	6.36e-05	0.000313	CcSEcCtD
Sitagliptin—Headache—Capecitabine—kidney cancer	6.33e-05	0.000311	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—kidney cancer	6.32e-05	0.000311	CcSEcCtD
Sitagliptin—ABCB1—renal system—kidney cancer	6.12e-05	0.0286	CbGeAlD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.01e-05	0.00269	CbGpPWpGaD
Sitagliptin—Nausea—Capecitabine—kidney cancer	6e-05	0.000295	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.93e-05	0.000292	CcSEcCtD
Sitagliptin—ABCB1—kidney—kidney cancer	5.92e-05	0.0277	CbGeAlD
Sitagliptin—Insomnia—Doxorubicin—kidney cancer	5.89e-05	0.00029	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	5.79e-05	0.00259	CbGpPWpGaD
Sitagliptin—Somnolence—Doxorubicin—kidney cancer	5.79e-05	0.000285	CcSEcCtD
Sitagliptin—ABCB1—cortex of kidney—kidney cancer	5.76e-05	0.027	CbGeAlD
Sitagliptin—CYP2C8—Biological oxidations—GSTT1—kidney cancer	5.75e-05	0.00258	CbGpPWpGaD
Sitagliptin—Dyspepsia—Doxorubicin—kidney cancer	5.73e-05	0.000282	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—kidney cancer	5.66e-05	0.000278	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.62e-05	0.000276	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—kidney cancer	5.61e-05	0.000276	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	5.59e-05	0.0025	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	5.59e-05	0.0025	CbGpPWpGaD
Sitagliptin—Pain—Doxorubicin—kidney cancer	5.57e-05	0.000274	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—kidney cancer	5.57e-05	0.000274	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS2—kidney cancer	5.55e-05	0.00248	CbGpPWpGaD
Sitagliptin—ABCB1—gonad—kidney cancer	5.49e-05	0.0257	CbGeAlD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	5.45e-05	0.00244	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—PTGS1—kidney cancer	5.39e-05	0.00241	CbGpPWpGaD
Sitagliptin—Feeling abnormal—Doxorubicin—kidney cancer	5.37e-05	0.000264	CcSEcCtD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	5.35e-05	0.0024	CbGpPWpGaD
Sitagliptin—Gastrointestinal pain—Doxorubicin—kidney cancer	5.32e-05	0.000262	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	5.3e-05	0.00237	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	5.25e-05	0.00235	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	5.2e-05	0.00233	CbGpPWpGaD
Sitagliptin—Urticaria—Doxorubicin—kidney cancer	5.17e-05	0.000254	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—kidney cancer	5.15e-05	0.000253	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.87e-05	0.00218	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Doxorubicin—kidney cancer	4.8e-05	0.000236	CcSEcCtD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.75e-05	0.00213	CbGpPWpGaD
Sitagliptin—Asthenia—Doxorubicin—kidney cancer	4.67e-05	0.00023	CcSEcCtD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	4.65e-05	0.00208	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	4.61e-05	0.00206	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—POMC—kidney cancer	4.5e-05	0.00201	CbGpPWpGaD
Sitagliptin—Diarrhoea—Doxorubicin—kidney cancer	4.45e-05	0.000219	CcSEcCtD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	4.33e-05	0.00194	CbGpPWpGaD
Sitagliptin—Dizziness—Doxorubicin—kidney cancer	4.31e-05	0.000212	CcSEcCtD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	4.27e-05	0.00191	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	4.23e-05	0.0019	CbGpPWpGaD
Sitagliptin—Vomiting—Doxorubicin—kidney cancer	4.14e-05	0.000204	CcSEcCtD
Sitagliptin—Rash—Doxorubicin—kidney cancer	4.11e-05	0.000202	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—kidney cancer	4.1e-05	0.000202	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—kidney cancer	4.08e-05	0.000201	CcSEcCtD
Sitagliptin—CYP2C8—Biological oxidations—GSTP1—kidney cancer	3.99e-05	0.00179	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	3.93e-05	0.00176	CbGpPWpGaD
Sitagliptin—Nausea—Doxorubicin—kidney cancer	3.87e-05	0.00019	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	3.8e-05	0.0017	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	3.8e-05	0.0017	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTM1—kidney cancer	3.66e-05	0.00164	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	3.61e-05	0.00162	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	3.56e-05	0.00159	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	3.56e-05	0.00159	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.51e-05	0.00157	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	3.49e-05	0.00156	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	3.47e-05	0.00156	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	3.43e-05	0.00153	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.23e-05	0.00145	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CTNNB1—kidney cancer	3.21e-05	0.00144	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	3.12e-05	0.0014	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL2—kidney cancer	3.11e-05	0.00139	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	3.09e-05	0.00139	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.09e-05	0.00138	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ACY1—kidney cancer	3.06e-05	0.00137	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	3.05e-05	0.00137	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.99e-05	0.00134	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.99e-05	0.00134	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.99e-05	0.00134	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.89e-05	0.0013	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ACY1—kidney cancer	2.66e-05	0.00119	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—kidney cancer	2.64e-05	0.00118	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.62e-05	0.00117	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.61e-05	0.00117	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PDHB—kidney cancer	2.6e-05	0.00116	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—POMC—kidney cancer	2.59e-05	0.00116	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CCBL1—kidney cancer	2.44e-05	0.00109	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PDHB—kidney cancer	2.26e-05	0.00101	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.21e-05	0.000989	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.18e-05	0.000976	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.14e-05	0.000958	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CCBL1—kidney cancer	2.13e-05	0.000953	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.12e-05	0.000948	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPAT—kidney cancer	2.12e-05	0.000948	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.11e-05	0.000945	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.09e-05	0.000936	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.07e-05	0.000927	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—FH—kidney cancer	1.97e-05	0.000881	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—APRT—kidney cancer	1.97e-05	0.000881	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.97e-05	0.00088	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.94e-05	0.000868	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.92e-05	0.000861	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.86e-05	0.000835	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GPC3—kidney cancer	1.85e-05	0.000829	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GLIPR1—kidney cancer	1.84e-05	0.000826	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPAT—kidney cancer	1.84e-05	0.000826	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.84e-05	0.000823	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA2—kidney cancer	1.8e-05	0.000806	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALAD—kidney cancer	1.75e-05	0.000786	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—APRT—kidney cancer	1.72e-05	0.000768	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—FH—kidney cancer	1.72e-05	0.000768	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.71e-05	0.000767	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.71e-05	0.000766	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.69e-05	0.000758	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.67e-05	0.000749	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.65e-05	0.000741	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ACY1—kidney cancer	1.64e-05	0.000734	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GPC3—kidney cancer	1.61e-05	0.000722	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PGK1—kidney cancer	1.6e-05	0.000719	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.6e-05	0.000719	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.57e-05	0.000705	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—LDHB—kidney cancer	1.57e-05	0.000705	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA2—kidney cancer	1.57e-05	0.000702	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.57e-05	0.000702	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALAD—kidney cancer	1.53e-05	0.000684	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.52e-05	0.000681	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.5e-05	0.000669	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.49e-05	0.000668	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.49e-05	0.000668	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.48e-05	0.000663	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.46e-05	0.000653	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.44e-05	0.000646	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PGK1—kidney cancer	1.4e-05	0.000626	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC5A3—kidney cancer	1.4e-05	0.000626	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PDHB—kidney cancer	1.39e-05	0.000624	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—POMC—kidney cancer	1.39e-05	0.000622	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—LDHB—kidney cancer	1.37e-05	0.000614	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA9—kidney cancer	1.36e-05	0.000611	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.33e-05	0.000597	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CCBL1—kidney cancer	1.31e-05	0.000587	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.3e-05	0.000584	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.23e-05	0.000552	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.2e-05	0.000537	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA9—kidney cancer	1.19e-05	0.000532	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.17e-05	0.000525	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CRABP1—kidney cancer	1.16e-05	0.000519	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.14e-05	0.000509	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPAT—kidney cancer	1.14e-05	0.000509	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.11e-05	0.000496	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ITPR2—kidney cancer	1.08e-05	0.000483	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—FH—kidney cancer	1.06e-05	0.000473	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—APRT—kidney cancer	1.06e-05	0.000473	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.02e-05	0.000456	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CRABP1—kidney cancer	1.01e-05	0.000453	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.94e-06	0.000445	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GPC3—kidney cancer	9.94e-06	0.000445	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.85e-06	0.000441	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ACHE—kidney cancer	9.84e-06	0.00044	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTT1—kidney cancer	9.84e-06	0.00044	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA2—kidney cancer	9.66e-06	0.000433	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALAD—kidney cancer	9.42e-06	0.000422	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ITPR2—kidney cancer	9.4e-06	0.000421	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SCARB1—kidney cancer	9.31e-06	0.000417	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS1—kidney cancer	9.22e-06	0.000413	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	9.19e-06	0.000412	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PSMD7—kidney cancer	9.04e-06	0.000405	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.98e-06	0.000402	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PGK1—kidney cancer	8.61e-06	0.000386	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.61e-06	0.000386	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTT1—kidney cancer	8.57e-06	0.000384	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ACHE—kidney cancer	8.57e-06	0.000384	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—BCHE—kidney cancer	8.57e-06	0.000384	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.46e-06	0.000379	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—LDHB—kidney cancer	8.45e-06	0.000378	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC2A1—kidney cancer	8.17e-06	0.000366	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SCARB1—kidney cancer	8.11e-06	0.000363	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS1—kidney cancer	8.03e-06	0.00036	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.93e-06	0.000355	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PSMD7—kidney cancer	7.88e-06	0.000353	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—BCHE—kidney cancer	7.47e-06	0.000334	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC5A5—kidney cancer	7.37e-06	0.00033	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA9—kidney cancer	7.32e-06	0.000328	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC2A1—kidney cancer	7.12e-06	0.000319	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.92e-06	0.00031	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTP1—kidney cancer	6.82e-06	0.000305	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.79e-06	0.000304	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ABCB1—kidney cancer	6.45e-06	0.000289	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTM1—kidney cancer	6.27e-06	0.000281	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CRABP1—kidney cancer	6.23e-06	0.000279	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTP1—kidney cancer	5.94e-06	0.000266	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.94e-06	0.000266	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ITPR2—kidney cancer	5.79e-06	0.000259	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTM1—kidney cancer	5.46e-06	0.000244	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTT1—kidney cancer	5.28e-06	0.000236	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ACHE—kidney cancer	5.28e-06	0.000236	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1A1—kidney cancer	5.17e-06	0.000232	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SCARB1—kidney cancer	5e-06	0.000224	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS1—kidney cancer	4.95e-06	0.000222	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.88e-06	0.000218	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PSMD7—kidney cancer	4.85e-06	0.000217	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—BCHE—kidney cancer	4.6e-06	0.000206	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.54e-06	0.000203	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—POMC—kidney cancer	4.43e-06	0.000198	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.39e-06	0.000196	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—POMC—kidney cancer	3.86e-06	0.000173	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTP1—kidney cancer	3.66e-06	0.000164	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS2—kidney cancer	3.53e-06	0.000158	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCB1—kidney cancer	3.46e-06	0.000155	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTM1—kidney cancer	3.36e-06	0.000151	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.19e-06	0.000143	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTEN—kidney cancer	3.08e-06	0.000138	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS2—kidney cancer	3.08e-06	0.000138	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTEN—kidney cancer	2.68e-06	0.00012	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—POMC—kidney cancer	2.38e-06	0.000106	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.17e-06	9.73e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS2—kidney cancer	1.9e-06	8.49e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—kidney cancer	1.89e-06	8.48e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTEN—kidney cancer	1.65e-06	7.4e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.17e-06	5.22e-05	CbGpPWpGaD
